and led by experienced Medical Device executives, TheraCell has further developed methodologies and gained patent protection for applying the oxygenation technology to demineralized bone matrix products. We have also developed a proprietary, patent pending process for the production of demineralized bone fibers. Our DBF™ technology has allowed the development of a number of Fiber Matrix™ products. We also have a proprietary, patent pending process to enhance the osteoinductivity of demineralized cancellous bone.